Cite Filings / DMRA / 0000902664-25-004918

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Damora Therapeutics, Inc. Filed 2025-11-13 Acc 0000902664-25-004918

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-12-05 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-17 3 Initial Statement of Ownership
2025-11-17 3 Initial Statement of Ownership
2025-11-17 SCHEDULE 13D Beneficial Ownership Report
2025-11-17 3 Initial Statement of Ownership
2025-11-13 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-10 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…